Skip to main content

hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis

Medically reviewed by Carmen Pope, BPharm. Last updated on June 27, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology.

Brittany N. Weber, M.D., Ph.D., from Brigham and Women's Hospital in Boston, and colleagues examined the longer-term association between clinically established thresholds for detectable hs-cTnT with MACE (acute coronary syndrome, stroke, and cardiovascular death) and all-cause mortality among 331 patients with RA.

The median calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk was 3.87 percent. The researchers found that 117 patients (35.3 percent) had detectable hs-cTnT (median level, 8.98 mg/dL). In 10 years, 16 MACE occurred (4.8 percent), with 50 all-cause deaths (15.1 percent). There was an association seen for detectable hs-cTnT with future MACE (hazard ratio [HR], 7.13); the significant association persisted after adjustment for ASCVD risk and log high-sensitivity C-reactive protein (hsCRP; HR, 4.29) and for baseline ASCVD risk and Disease Activity Score in 28 joints based on CRP (DAS28-CRP). Corresponding associations were seen for detectable hs-cTnT and all-cause mortality (HR, 7.2), which also persisted after adjustment (HRs, 4.18 and 4.74, respectively). ASCVD risk score alone was significantly associated with MACE.

"These findings suggest that hs-cTnT may be a useful marker to improve cardiovascular risk assessment among patients with RA with overall low estimated ASCVD risk," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Read this next

Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis

WEDNESDAY, April 30, 2025 -- Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published...

Adverse Pregnancy Outcomes Partly Mediate Association Between Prepregnancy Obesity, CVD Risk

MONDAY, April 21, 2025 -- Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in...

Handheld Electro-Shockers Pose Risk for Interaction With Implantable Cardiac Devices

WEDNESDAY, April 9, 2025 -- When applied to cardiac implantable electronic devices (CIEDs), commercially available handheld electro-shockers pose a relevant risk for interaction...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.